Simvastatin attenuated cerebrovascular cell proliferation in the development of hypertension through Rho/Rho-kinase

Related Experiment Video

Updated: May 24, 2026

Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay
13:51

Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay

Published on: November 11, 2018

Ming-Ming Ma1, Shi-Yang Li, Mi Wang

  • 1Department of Pharmacology, Cardiac and Cerebrovascular Research Center, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, People's Republic of China.

Journal of Cardiovascular Pharmacology
|March 7, 2012
PubMed

Insights

Simvastatin treatment reduced cell proliferation in hypertensive rats by inhibiting the Rho/Rho-kinase pathway. This offers potential protection against stroke and vascular remodeling.

Area of Science:

  • Cardiovascular Research
  • Pharmacology
  • Molecular Biology

Background:

  • Cerebrovascular remodeling is a key feature of hypertension, increasing stroke risk.
  • Statins may counteract vascular remodeling by inhibiting the Rho/Rho-kinase pathway.
  • Hypertension is linked to pathological changes in the basilar artery.

Purpose of the Study:

  • To investigate the effect of simvastatin on the Rho/Rho-kinase pathway in a rat model of hypertension.
  • To determine if simvastatin can ameliorate hypertension-induced basilar artery changes by downregulating cell proliferation.
  • To explore the role of the Rho/Rho-kinase pathway in endothelin-1 (ET-1) induced proliferation.

Main Methods:

  • Utilized a two-kid, two-clip rat model to induce hypertension.
  • Assessed simvastatin's impact on the Rho/Rho-kinase pathway activity.
  • Employed CCK-8 assay to measure proliferation rates in basilar artery smooth muscle cells.

Main Results:

  • Elevated plasma endothelin-1 (ET-1) and Rho/Rho-kinase activity correlated with blood pressure in hypertensive rats.
  • Simvastatin effectively reduced Rho/Rho-kinase activity and cell proliferation.
  • Simvastatin, C3, and Y27632 inhibited ET-1-induced proliferation via the Rho/Rho-kinase pathway.

Conclusions:

  • Simvastatin attenuates ET-1-induced proliferation in hypertensive rat basilar arteries through the Rho/Rho-kinase pathway.
  • Simvastatin demonstrates potential as a therapeutic agent to prevent vascular remodeling and stroke.
  • Targeting the Rho/Rho-kinase pathway offers a promising strategy for managing hypertension-related cerebrovascular complications.

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Regulation of Stroke Volume01:27

Regulation of Stroke Volume

The regulation of stroke volume, which is the amount of blood the heart pumps out during each heartbeat, is critical for maintaining a healthy circulatory system. Stroke volume is influenced by three main factors: preload, contractility, and afterload.
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...